Cargando…
Gemcitabine, oxaliplatin and 5-FU in advanced bile duct and gallbladder carcinoma: two parallel, multicentre phase-II trials
BACKGROUND: Gemcitabine, oxaliplatin and 5-fluorouracil (5-FU) are active in biliary tract cancer and have a potentially synergistic mode of action and non-overlapping toxicity. The objective of these trials was to determine response, survival and toxicity separately in patients with bile duct cance...
Autores principales: | Wagner, A D, Buechner-Steudel, P, Moehler, M, Schmalenberg, H, Behrens, R, Fahlke, J, Wein, A, Behl, S, Kuss, O, Kleber, G, Fleig, W E |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2009
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2788250/ https://www.ncbi.nlm.nih.gov/pubmed/19904267 http://dx.doi.org/10.1038/sj.bjc.6605377 |
Ejemplares similares
-
Diseases of the Gallbladder and Bile Ducts
Publicado: (1940) -
Lymphoid Hyperplasia of the Gallbladder Extending to the Bile Duct
por: Miyamoto, Kazuya, et al.
Publicado: (2022) -
Feasibility of perioperative chemotherapy with infusional 5-FU, leucovorin, and oxaliplatin with (FLOT) or without (FLO) docetaxel in elderly patients with locally advanced esophagogastric cancer
por: Lorenzen, S, et al.
Publicado: (2013) -
To Resect or Not to Resect Extrahepatic Bile Duct in Gallbladder Cancer?
por: Gavriilidis, Paschalis, et al.
Publicado: (2017) -
A Multicenter Phase II Trial of Gemcitabine Plus Oxaliplatin in Unresectable Gallbladder Cancer
por: Woo, Sang Myung, et al.
Publicado: (2013)